003850 — Boryung Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Boryung, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	627,279	760,476	859,626	1,017,107	1,017,427
Cost of Revenue
Gross Profit	264,937	307,187	353,430	363,357	372,282
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	585,831	705,480	791,359	952,687	950,990
Operating Profit	41,448	54,996	68,267	64,419	66,437
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	70,718	58,872	56,306	62,959	69,849
Provision for Income Taxes
Net Income After Taxes	43,119	41,938	40,213	69,636	64,303
Minority Interest
Net Income Before Extraordinary Items
Net Income	43,044	41,894	40,203	69,633	64,303
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	43,044	41,894	40,203	69,633	64,303
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	687	655	612	1,074	752
Dividends per Share